Novartis AG (NVS)

Last Closing Price: 97.09 (2024-04-29)

Return on Equity (Annual)

Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity

Novartis AG (NVS) had Return on Equity of 18.34% for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$46.66B
$14.85B
$12.47B
$34.19B
$36.89B
$9.77B
$-646.00M
$9.12B
$9.12B
$8.57B
$8.57B
$14.85B
$8.57B
$9.77B
$18.15B
2.08B
2.09B
$7.15
$7.10
Balance Sheet Financials
$30.48B
$9.51B
$69.46B
$99.94B
$26.39B
$18.44B
$26.80B
$53.20B
$46.75B
$-3.47B
$46.75B
2.04B
Cash Flow Statement Financials
$14.46B
$5.60B
$-14.28B
$7.52B
$13.39B
$5.88B
$865.00M
$-7.25B
--
Fundamental Metrics & Ratios
1.16
--
--
0.28
0.53
73.27%
20.94%
20.94%
38.90%
19.55%
31.83%
$13.63B
--
--
--
0.47
2.11
6.19
58.93
Return on Equity
18.34%
-247.03%
8.58%
13.15%
$22.87
$6.52
$6.91